PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2021 > Announcement of Changes in Board of Directors at PHC Holdings Corporation Effective August 13, 2021

News


2021

NewsAugust 13

Announcement of Changes in Board of Directors at PHC Holdings Corporation Effective August 13, 2021

Please be advised of the changes in Board of Directors at PHC Holdings Corporation (headquarters: Minato-ku, Tokyo) effective August 13, 2021.

(1) New Appointment on August 13, 2021

Position/Title Name Remarks
Corporate Auditor
(Independent External Auditor)
Shannon Hansen  

(2) Resignation on August 13, 2021

Position/Title Name Remarks
Corporate Auditor Ken Matsumura KKR Japan Limited

(3) Board of Directors at PHC Holdings Corporation on August 13, 2021

Members of Board, Corporate Auditors

Position/Title Name Remarks
President,
Member of Board
John Marotta
Executive Vice President,
Member of Board
Shoji Miyazaki Director(part-time),
PHC Corporation
Director,
Member of Board
Hirofumi Hirano President,
KKR Japan Limited
Director,
Member of Board
Koichiro Sato MBK HEALTHCARE MANAGEMENT PTE. LTD.
Hong Kong Branch, CEO
Director,
Member of Board
Tatsunobu Fukushima General Manager,
Corporate Planning Department
Life Science Institute, Inc.
Director,
Member of Board
(Lead Independent External Director)
Alan Malus
Director,
Member of Board
(Independent External Director)
Kyoko Deguchi
Corporate Auditor Koichi Ikeuchi Corporate Auditor,
PHC Corporation
Corporate Auditor
(Independent External Auditor)
Noriaki Yamada Clifix Certified Public Tax Accountant’s Corporation
Corporate Auditor
(Independent External Auditor)
Shannon Hansen

Corporate Officers

Position/Title Name Remarks
Chief Executive Officer (CEO) John Marotta President
Chief Operating Officer (COO)
In Charge of Risk Management
Shoji Miyazaki Executive Vice President
Director (part-time), PHC Corporation
Corporate Officer,
Chief Financial Officer (CFO)
Frederick Reidenbach  
Corporate Officer,
Chief Strategic Officer (CSO),
In Charge of Corporate Planning/
Business Development/
External Affairs
Ryuichi Hirashima  
Corporate Officer,
Head of Diabetes Management Domain
Robert Schumm President,
Ascensia Diabetes Care Holdings AG
Corporate Officer,
In Charge of Engineering/Manufacturing
Kyoji Morimoto President,
PHC Corporation
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain
Nobuaki Nakamura Director, Member of Board
Biomedical Division, PHC Corporation
Corporate Officer,
Co-head of Healthcare Solutions Domain
Takayuki Otsuka Director, Member of Board
Medical information Systems Division,
PHC Corporation
Corporate Officer,
Co-head of Healthcare Solutions Domain
Haruo Watanabe President and Chief Executive Officer,
LSI Medience Corporation
Corporate Officer,
General Counsel
Ephraim Starr
Corporate Officer,
Chief Human Resources Officer (CHRO)
Jon Ebina
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain
John Sweeney President, Epredia
Corporate Officer,
(concurrent assignment as)
General Manager,
Corporate Planning Department
Kaiju Yamaguchi

Media contact

Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.